UK markets closed

Immunome, Inc. (IMNM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
14.92-1.12 (-6.98%)
At close: 04:00PM EDT
14.92 0.00 (0.00%)
After hours: 07:32PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close16.04
Open15.74
Bid14.90 x 600
Ask14.96 x 600
Day's range14.72 - 16.05
52-week range5.26 - 30.96
Volume898,216
Avg. volume776,428
Market cap894.736M
Beta (5Y monthly)1.85
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Immunome Announces Completion of Purchase of Assets from Atreca

    BOTHELL, Wash., May 20, 2024--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the completion of its purchase of antibodies and related assets from Atreca, Inc. Under the terms of the agreement, Immunome paid Atreca $5.5 million upfront, and Atreca will be eligible for up to $7.0 million in clinical development milestones. Immunome received the rights to 28 antibodies as well as certain materi

  • Business Wire

    Immunome Announces Promotion of Max Rosett to Chief Financial Officer

    BOTHELL, Wash., May 17, 2024--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the promotion of Max Rosett to Chief Financial Officer, effective May 9. Mr. Rosett most recently held the role of Executive Vice President, Operations, in addition to serving as Immunome’s Interim Chief Financial Officer since January 2024.

  • Business Wire

    Immunome Reports First Quarter 2024 Financial Results and Provides Business Update

    BOTHELL, Wash., May 14, 2024--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the first quarter ended March 31, 2024, and provided a business update.